Although the majority of published literature largely associates Hh signaling with increased angiogenesis, several reports have emerged in pancreatic cancer models showing increased vascularization enhancing drug delivery upon the inhibition of paracrine Hh signaling in pancreatic stroma using SMO inhibitors [94–96]. This evidence concerns the gene SMO and pancreatic neoplasm.